radar-logo-white

Bahia Software

Organization details

Area of expertise:​
Data management Decision support for smart AMR management Information and communication systems Open platform Other Smart AMR management and control systems Use of AI in smart AMR management
Company type:​
Private company
Seeking for:​
Antimicrobial susceptibility testing Detection system for MDROs - after culture Detection system for MDROs - direct from sample Detection system to differentiate virus from bacteria Molecular detection of MDROs Point of care testing Rapid identification of microorganisms
Organization size:

More than 250

Headquarters country:

Spain

Website:

Contact

Contact person:

Cristóbal Bernardo Castiñeira

Email:

cristobal.bernardo@bahiasoftware.es

BAHÍA SOFTWARE is a technology company focused on the development of products and services to public and private health hospitals as well as regional health services. Our company also has an extensive knowledge of medical standards, interoperability and corporate systemes in the field of healthcare mentioned in the iRADAR PPI (GACELA, ARGOS, SILICON, OSABIDE, etc). Our innovation department has undertaken R&D projects in the field of antimicrobial resistance to manage and address this issue within hospital environments. The department also has a strong knowedge and experience in the implementation of PPI , and PCP projects working at national and European Levels.

In connection with iRADAR PPI, we have participated in the ANTISUPERBUGS-PCP and are currently involved in the GRALENIA project. GRALENIA is a large R&D project that aims to harness information from healthcare systems through artificial intelligence for predicting infections caused by resistant bacteria, as well as managing patients with these issues to enhance their treatment. Our experience in interoperability, the development of software platforms for the healthcare sector, and our involvement in these R&D projects make us a suitable candidate to participate in iRADAR PPI.

We are interested in establishing contact with companies developing rapid diagnostic technologies that may be interested in collaborating with us on the development of a joint solution

Seeking (additional informations)

We are interested in establishing contact with companies developing rapid diagnostic technologies that may be interested in collaborating with us on the development of a joint solution